APA

Diamanti-Kandarakis E., Palioniko G., Alexandraki K., Bergiele A., Koutsouba T. & Bartzis M. (20040729). The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. : European journal of endocrinology.

Chicago

Diamanti-Kandarakis Evanthia, Palioniko Gaetano, Alexandraki Krystallenia, Bergiele Angeliki, Koutsouba Thenia and Bartzis Michael. 20040729. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. : European journal of endocrinology.

Harvard

Diamanti-Kandarakis E., Palioniko G., Alexandraki K., Bergiele A., Koutsouba T. and Bartzis M. (20040729). The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. : European journal of endocrinology.

MLA

Diamanti-Kandarakis Evanthia, Palioniko Gaetano, Alexandraki Krystallenia, Bergiele Angeliki, Koutsouba Thenia and Bartzis Michael. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. : European journal of endocrinology. 20040729.